课题基金 / 基金详情

项目摘要

项目成果

Kun-Liang Guan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):Hippo肿瘤抑制通路通过抑制增殖和诱导细胞凋亡来限制组织生长和器官大小。Hippo通路的失调有助于肿瘤的发生。Hippo通路的关键下游效应物是转录共激活因子YAP,它被Hippo通路激酶Lats磷酸化并抑制。在人类癌症中发现了YAP的过度表达和过度激活。广泛的研究已经确定了许多调节Hippo通路的细胞内蛋白。然而,关于Hippo通路的细胞外信号和细胞表面受体的关键问题尚未得到解决。我们最近发现g蛋白偶联受体(GPCR)及其同源配体调节Hippo通路。GPCR调节多种细胞内信号分子,包括蛋白激酶A (PKA)和蛋白激酶C (PKC)。PKA是由cAMP激活的,cAMP是通过刺激gs偶联受体而升高的第二信使。PKC被二酰基甘油激活,二酰基甘油也是Gq/11偶联受体升高的第二信使。PKA和PKC都参与广泛的细胞调控,包括基因表达和细胞生长。我们的初步研究表明PKA和PKC可以有效地调节YAP。PKA通过增加磷酸化抑制YAP, PKC通过诱导去磷酸化激活YAP。本项目的长期目标是阐明PKA和PKC调控YAP的机制,了解Hippo-YAP通路在细胞生长、器官大小、肿瘤发生和肿瘤转移中的调控和功能,为癌症治疗提供潜在的治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): The Hippo tumor suppressor pathway functions to limit tissue growth and organ size by inhibiting proliferation and inducing apoptosis. Dysregulation of the Hippo pathway contributes to tumorigenesis. The key downstream effectors of the Hippo pathway are the transcription co-activator YAP, which is phosphorylated and inhibited by the Hippo pathway kinase Lats. YAP overexpression and hyperactivation are found in human cancers. Extensive studies have identified many intracellular proteins that modulate the Hippo pathway. However, key questions regarding the extracellular signals and cell surface receptors for the Hippo pathway have not been addressed. We recently discovered that G-protein coupled receptors (GPCR) and their cognate ligands regulate the Hippo pathway. GPCR modulates many intracellular signaling molecules including protein kinase A (PKA) and protein kinase C (PKC). PKA is activated by cAMP, a second messenger that is elevated by stimulation of Gs-coupled receptor. PKC is activated by diacylglycerol that is also a second messenger elevated by Gq/11- coupled receptors. Both PKA and PKC are involved in a wide range of cellular regulation, including gene expression and cell growth. Our preliminary studies reveal that PKA and PKC potently modulate YAP. PKA inhibits YAP by increasing phosphorylation while PKC activates YAP by inducing dephosphorylation. The long- term goal of this project is to elucidate the mechanism of YAP regulation by PKA and PKC, to understand the regulation and function of the Hippo-YAP pathway in cell growth, organ size, tumorigenesis and cancer metastasis, and to provide potential therapeutic targets for cancer treatment.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.semcdb.2012.05.004
发表时间: 2012-09
期刊: SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
影响因子: 7.3
作者: [Hong, Wanjin, Guan, Kun-Liang]
通讯作者: Guan, Kun-Liang
DOI: 10.1101/gad.262816.115
发表时间: 2015-06-15
期刊: Genes & development
影响因子: 10.5
作者: [Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL]
通讯作者: Guan KL
DOI: 10.1016/j.tcb.2015.05.002
发表时间: 2015-09
期刊: Trends in cell biology
影响因子: 19
作者: [Hansen CG, Moroishi T, Guan KL]
通讯作者: Guan KL
The emerging roles of YAP and TAZ in cancer.
YAP和TAZ在癌症中的新兴作用。
DOI: 10.1038/nrc3876
发表时间: 2015-02
期刊: Nature reviews. Cancer
影响因子: --
作者: [Moroishi T, Hansen CG, Guan KL]
通讯作者: Guan KL
Functional interplay between Hippo and estrogen receptor ESR1
Molecular Mechanism and Therapy for Ocular Melanoma
Molecular Mechanism and Therapy for Ocular Melanoma
The mTOR and Hippo pathway in cell growth and cancer
海外基金